{"id":110341,"name":"LILLY USA, LLC","slug":"lilly-usa-llc","state":"IN","description":"Pharmaceuticals","totalSpending":1290000,"filings":19,"yearlySpending":[{"year":2019,"income":30000},{"year":2020,"income":230000},{"year":2021,"income":240000},{"year":2022,"income":180000},{"year":2024,"income":250000},{"year":2025,"income":360000}],"firms":["BROWNSTEIN HYATT FARBER SCHRECK, LLP"],"lobbyists":["MARC LAMPKIN","ZACHARY PFISTER","BRIAN WILD","BRIAN MCKEON","NADEAM ELSHAMI","EMILY FELDER","WILLIAM MOSCHELLA","MARK PRYOR","CARMENCITA WHONDER","ADAM STEINMETZ","DEEMA TARAZI","DAVID REID","ARI ZIMMERMAN","BRANDT ANDERSON","BRIAN MCGUIRE","GREGORY SUNSTRUM","STEPHEN HOLLAND"],"issues":["PHA","MED","MMM","HCR","TAX"],"sampleDescriptions":["Issues related to the pharmaceutical industry","Issues related to the pharmaceutical industry\nHR 748 CARES Act - Issues related to COVID-19 relief","Issues related to the pharmaceutical industry\nIssues related to COVID-19 relief","Issues related to the pharmaceutical industry\nIssues related to COVID-19 relief\nH.R.133 - Consolidated Appropriations Act, 2021","Issues related to the pharmaceutical industry, Issues related to COVID-19 relief\nH.R.1319 - American Rescue Plan Act of 2021","Issues related to the pharmaceutical industry, Issues related to COVID-19 relief","Issues related to the pharmaceutical industry, Issues related to COVID-19 relief\nH.R.3684 - Infrastructure Investment and Jobs Act","Issues related to the pharmaceutical industry, Issues related to COVID-19 relief\nH.R.3684 - Infrastructure Investment and Jobs Act\nH.R.5376 - Build Back Better Act","Issues related to the pharmaceutical industry, Issues related to COVID-19 relief H.R.3684 - Infrastructure Investment and Jobs Act H.R.5376 - Build Back Better Act","Issues related to the pharmaceutical industry Issues related to COVID-19 relief H.R. 5376 - Build Back Better Act","Issues related to the pharmaceutical industry H.R. 5376, Build Back Better Act Inflation Reduction Act","Issues related to the pharmaceutical industry Issues related to Inflation Reduction Act Implementation H.R. 4818 Treat and Reduce Obesity Act","Issues related to biotechnology legislation Diagnostic tests Clinical trial issues Issues related to supply chain","H.R. 7024 Tax Relief for American Families and Workers Act of 2024","Issues related to the pharmaceutical industry Issues related to Inflation Reduction Act Implementation Treat and Reduce Obesity Act","Issues related to biotechnology legislation Diagnostic tests clinical trial issues issues related to supply chain","Issues related to the pharmaceutical industry Issues related to Inflation Reduction Act Implementation Treat and Reduce Obesity Act Pharmaceutical tariffs","Issues related to the pharmaceutical industry Issues related to Inflation Reduction Act Implementation Treat and Reduce Obesity Act Pharmaceutical tariffs Safe Drugs Act"],"years":[2019,2020,2021,2022,2024,2025]}